GlassScriptPhysician profile
April M Melvin
NPI 1770214934
$3,526.81
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,229 · 2023: $239 · 2024: $1,834 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.05 |
| Travel and Lodging | $1,057.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,957.85 | 2022-2025 | Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.84 | 2023-2025 | Lifevest |
| Pfizer INC. | $87.38 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $37.38 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $36.34 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.81 | 2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $26.48 | 2022 | |
| Inspire Medical Systems, INC. | $24.87 | 2025 | Inspire |
| Atricure, INC. | $24.57 | 2024 | |
| Heartflow, INC. | $21.50 | 2024 | |
| Novo Nordisk INC | $21.36 | 2025 | Wegovy |
| Cvrx, INC. | $19.51 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $18.44 | 2024 | Evkeeza |
| Alnylam Pharmaceuticals INC. | $17.07 | 2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $13.84 | 2024 | Brilinta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Melvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.